Aurobindo Pharma Buyback 2026 vs EMA Partners India Buyback 2026

Comparison between Aurobindo Pharma Buyback 2026 and EMA Partners India Buyback 2026.

Buyback Details

Aurobindo Pharma Buyback 2026 is a Tender Offer buyback proposed to list at BSE, NSE while EMA Partners India Buyback 2026 is a Tender Offer proposed to list at NSE.

 Aurobindo Pharma LtdEma Partners India Ltd.
LogoAurobindo Pharma Buyback 2026 LogoEMA Partners India Buyback 2026 Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSENSE
Face Value₹10 per share₹5 per share
Buyback Price₹1475 per share₹100 per share
Issue Size54,23,728 shares7,25,000 shares
Issue Size (Amount)₹800.00 Crores₹7.25 Crores
Buyback Ratio
CategoryEntitlement RatioShares Offered
Small Shareholders7 : 618,13,560
General Category2 : 24946,10,168

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

CategoryEntitlement RatioShares Offered
Small Shareholders3 : 311,08,750
General Category10 : 3596,16,250

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

RegistrarKfin Technologies Ltd.Bigshare Services Pvt.Ltd.
Lead ManagersAxis Capital Ltd.Indorient Financial Services Ltd.
Necessity of the buyback

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Optimise the Company’s capital structure.
  • Improve financial ratios such as earnings per share and return on equity.
  • Enhance long-term shareholder value.
  • Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Optimise the Company’s capital structure.
  • Improve financial ratios such as earnings per share and return on equity.

Buyback Timetable

Aurobindo Pharma Buyback 2026 and EMA Partners India Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aurobindo Pharma Buyback 2026 Buyback record date is Apr 17, 2026. EMA Partners India Buyback 2026 Buyback record date is Apr 30, 2026.

 Aurobindo Pharma LtdEma Partners India Ltd.
Record DateApr 17, 2026Apr 30, 2026
Offer Open DateApr 23, 2026May 07, 2026
Offer Closure DateApr 29, 2026May 13, 2026
Last date for receipt of tender formsApr 29, 2026May 13, 2026
Finalisation of buybackMay 07, 2026May 19, 2026
Last Date for settlment of bidsMay 07, 2026May 22, 2026
Last Date for extinguishment of sharesMay 18, 2026Jun 03, 2026

Financial Details and Other Relevent Information

Comparison of Aurobindo Pharma Buyback 2026 and EMA Partners India Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Aurobindo Pharma LtdEma Partners India Ltd.
Financial

Company Financials (Restated Consolidated)

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets49,784.9745,071.5139,889.99
Total Income32,345.5829,559.2525,145.97
Profit After Tax1,582.721,211.02684.85
EBITDA6,605.005,843.003,758.00
NET Worth32,647.0029,851.00
Reserves and Surplus20,476.0319,664.2317,975.44
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended31 Jul 202431 Mar 202431 Mar 2023
Assets75.0576.5953.26
Total Income26.3368.8351.06
Profit After Tax4.3714.273.07
NET Worth57.8353.7439.46
Reserves and Surplus58.0653.9739.93
Total Borrowing7.247.580.56
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Mar-2026 1330.90 1180.00 1272.16
Feb-2026 1250.85 1106.25 1179.45
Jan-2026 1270.40 1115.80 1176.03
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Mar-2026 1330.00 1179.80 1272.09
Feb-2026 1250.90 1106.00 1179.10
Jan-2026 1270.80 1116.20 1175.87

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Apr-2026 95.00 68.35 82.05
Mar-2026 87.00 65.25 77.68
Feb-2026 94.00 77.00 88.09

Compare with others

Compare:

Aurobindo Pharma Buyback 2026 and EMA Partners India Buyback 2026